Brief: Germany's Evotec Gets Takeover Interest From Halozyme At About 11 Euros Per Share - Bloomberg News
Nov 14 (Reuters) -
* GERMANY'S EVOTEC GETS TAKEOVER INTEREST FROM HALOZYME AT
ABOUT
€11 PER SHARE - BLOOMBERG NEWS
Source text: https://tinyurl.com/2veteceh
Further company coverage: EVTG.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Halozyme Therapeutics
See all newsUS RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Halozyme wins court order to block Merck's injected Keytruda in select European markets (updated)
US STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
Halozyme wins court order to block Merck's injected Keytruda in select European markets